Pharmacological evaluation of gatifloxacin in chemically induced hepatocarcinogenesis: A new tool for hepatocellularcarcinoma treatment

Journal of Cancer Science and Therapy

Volumn 5, Issue 1, 2013, Pages 18-22

  Afzal, Muhammad ^a   Kazmi, Imran ^a   Khan, Ruqaiyah ^a   Singh, Rajbala ^a   Pravez, Mohammad ^b   Imam, Faisal ^b   Anwar, Firoz ^a  

^a Siddhartha Institute of Pharmacy   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Carcinogen; DENA; Gatifloxacin; Hepatocellular carcinoma; Histology

Indexed keywords

ACID PHOSPHATASE; ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GATIFLOXACIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CHEMOPROPHYLAXIS; CONTROLLED STUDY; HISTOLOGY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER PARENCHYMA; NONHUMAN; RAT;

EID: 84873198007     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000179     Document Type: Article

References (27)

1. Plymoth A, Chemin I, Boffetta P, Hainaut P (2009) Editorial foreword special issue "hepatocellular carcinoma--a worldwide translational approach". Cancer Lett 286: 3-4.
2. Murugavel KG, Naranatt PP, Shankar EM, Mathews S, Raghuram K, et al. (2007) Prevalence of aflatoxin B1 in liver biopsies of proven hepatocellular carcinoma in India determined by an in-house immunoperoxidase test. J Med Microbiol 56: 1455-1459.
3. Economist Intelligence Unit (2009) Breakway: the globalburden of cancer,challenges and opputunities: A report from the Economist Intelligence Unit: 16.
4. Ciemniak A (2006) A comparison of N-nitrosodimethylamine contents in selected meat products. Rocz Panstw Zakl Hig 57: 341-346.
5. Al-Rejaie SS, Aleisa AM, Al-Yahya AA, Bakheet SA, Alsheikh A, et al. (2009) Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats. World J Gastroenterol 15: 1373-1380.
6. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160: 1-40.
7. Chakraborty T, Chatterjee A, Rana A, Dhachinamoorthi D, Kumar PA, et al. (2007) Carcinogen-induced early molecular events and its implication in the initiation of chemical hepatocarcinogenesis in rats: chemopreventive role of vanadium on this process. Biochim Biophys Acta 1772: 48-59.
8. Panda AK (2011) Notification by Ministry of Health and Family Welfare. The Gazette of India: 984G1.
9. Alwahaibi N, Mohamed J, Alhamadani A (2010) Supplementation of selenium reduces chemical hepatocarcinogenesis in male Sprague-Dawley rats. J Trace Elem Med Biol 24: 119-123.
10. Wan XY, Luo M, Li XD, He P (2009) Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine. Chem Biol Interact 181: 15-19.
11. 1-mediated hepatocellular carcinoma. Fitoterapia 70: 279-283.
12. Bishayee A, Bhatia D, Thoppil RJ, Darvesh AS, Nevo E, et al. (2011) Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis 32: 888-896.
13. Thirunavukkarasu C, Sakthisekaran D (2003) Sodium selenite modulates tumour marker indices in N-nitrosodiethylamine-initiated and phenobarbital-promoted rat liver carcinogenesis. Cell Biochem Funct 21: 147-153.
14. Carr BI, Lu SN, Pancoska P (2011) Small hepatocellular carcinoma in Chinese patients. Hepatogastroenterology 58: 1334-1342.
15. Pancoska P, De Giorgio M, Fagiuoli S, Carr BI (2011) Small HCCs identified by screening. Dig Dis Sci 56: 3078-3085.
16. Sherman M (2009) Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment. Cleve Clin J Med 76: S6-S9.
17. Lucier GW, Tritscher A, Goldsworthy T, Foley J, Clark G, et al. (1991) Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res 51: 1391-1397.
18. Jiang J, Nilsson-Ehle P, Xu N (2006) Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis 5: 4.
19. Abel S, De Kock M, van Schalkwyk DJ, Swanevelder S, Kew MC, et al. (2009) Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma. Prostaglandins Leukot Essent Fatty Acids 81: 391-399.
20. Bartsch H, Nair J, Owen RW (1999) Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis 20: 2209-2218.
21. Tapiero H, Ba GN, Couvreur P, Tew KD (2002) Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed Pharmacother 56: 215-222.
22. Lopez JB (2005) Recent developments in the first detection of hepatocellular carcinoma. Clin Biochem Rev 26: 65-79.
23. Afzal M, Kazmi I, Gupta G, Rahman M, Kimothi V, et al. (2012) Preventive effect of Metformin against N-nitrosodiethylamine-initiated hepatocellular carcinoma in rats. Saudi Pharmaceutical Journal 20: 365-370.
24. Maideen NM, Velayutham R, Manavalan G (2012) Activity of prosopis cineraria against N-nitrosodiethylamine induced liver tumors by regulating the levels of tumor marker lipid peroxidation and Antioxidants. AJPLS 2: 1-9.
25. Borges LP, Borges VC, Moro AV, Nogueira CW, Rocha JB, et al. (2005) Protective effect of diphenyl diselenide on acute liver damage induced by 2-nitropropane in rats. Toxicology 210: 1-8.
26. Yeo W, Mo FK, Koh J, Chan AT, Leung T, et al. (2006) Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol 17: 1083-1089.
27. Riahi S, Ganjali MR, Bagheri M (2009) Theoretical investigation of interaction between Gatifloxacin and DNA: Implications for anticancer drug design. Mat Sci Engineering C 29: 1808-1813.